- Home
- ERO vs TVTX Comparison
ERO vs TVTX Comparison
Compare ERO & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERO
- TVTX
- Stock Information
- Founded
- ERO 2016
- TVTX 2008
- Country
- ERO Canada
- TVTX United States
- Employees
- ERO N/A
- TVTX N/A
- Industry
- ERO
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ERO
- TVTX Health Care
- Exchange
- ERO Nasdaq
- TVTX Nasdaq
- Market Cap
- ERO 1.3B
- TVTX 1.4B
- IPO Year
- ERO N/A
- TVTX N/A
- Fundamental
- Price
- ERO $15.60
- TVTX $14.41
- Analyst Decision
- ERO Strong Buy
- TVTX Strong Buy
- Analyst Count
- ERO 1
- TVTX 15
- Target Price
- ERO $19.00
- TVTX $33.57
- AVG Volume (30 Days)
- ERO 474.1K
- TVTX 1.6M
- Earning Date
- ERO 07-31-2025
- TVTX 07-31-2025
- Dividend Yield
- ERO N/A
- TVTX N/A
- EPS Growth
- ERO N/A
- TVTX N/A
- EPS
- ERO 0.18
- TVTX N/A
- Revenue
- ERO $489,554,000.00
- TVTX $273,533,000.00
- Revenue This Year
- ERO $73.94
- TVTX $73.84
- Revenue Next Year
- ERO $20.16
- TVTX $46.72
- P/E Ratio
- ERO $85.70
- TVTX N/A
- Revenue Growth
- ERO 13.24
- TVTX 75.65
- 52 Week Low
- ERO $9.30
- TVTX $6.80
- 52 Week High
- ERO $23.40
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- ERO 60.56
- TVTX 39.07
- Support Level
- ERO $14.90
- TVTX $14.33
- Resistance Level
- ERO $15.89
- TVTX $15.04
- Average True Range (ATR)
- ERO 0.52
- TVTX 0.70
- MACD
- ERO -0.05
- TVTX 0.01
- Stochastic Oscillator
- ERO 65.61
- TVTX 30.11
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.